Inhibition of the self-cleavage reaction of the human hepatitis delta virus ribozyme by antibiotics

Journal of Molecular Biology

Volumn 259, Issue 5, 1996, Pages 916-925

  Rogers, Jeff ^a   Chang, Alex H ^b   Von Ahsen, Uwe ^b   Schroeder, Renée ^b   Davies, Julian ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Antiviral; Catalytic RNA; MgCl2; Neomycin; RNA footprint

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIBIOTIC AGENT; LEAD ACETATE; MAGNESIUM ION; NEOMYCIN; POLYPEPTIDE ANTIBIOTIC AGENT; RIBOZYME; TETRACYCLINE DERIVATIVE; UNINDEXED DRUG;

ARTICLE; CATALYSIS; CONCENTRATION RESPONSE; CONTROLLED STUDY; HEPATITIS DELTA VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; RNA SEQUENCE; RNA VIRUS; VIRUS REPLICATION;

EID: 0343799864     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1996.0369     Document Type: Article

References (32)

1. Bass, B. L. & Cech T. R. (1986). Ribozyme inhibitors: deoxyguanosine and dideoxyguanosine are competitive inhibitors of self-splicing of the Tetrahymena ribosomal ribonucleic acid precursor. Biochemistry, 25, 4473-4477.
2. Botto, R. E. & Coxon, B. (1983). Nitrogen-15 nuclear magnetic resonance spectroscopy of neomycin B and related aminoglycosides. J. Am. Chem. Soc. 105, 1021-1028.
3. Brown, R. S., Hingerty, B. E., Dewan, J.C. & Klug, A. (1983). Pb(II)-catalyzed cleavage of the sugar-phosphate backbone of yeast tRNA Phe -implications for lead toxicity and self-splicing RNA. Nature, 303, 543-546.
4. Chopra, I. (1994). Tetracycline analogs whose primary target is not the bacterial ribosome. Antimicrob. Agents Chemother, 38, 637-640.
5. Clouet-d'Orval B., Stage T. K. & Uhlenbeck O. C. (1995). Neomycin inhibition of the hammerhead ribozyme involves ionic interactions. Biochemistry, 34, 11186-11190.
6. Davies, J., von Ahsen, U. & Schroeder, R. (1993). Antibiotics and the RNA world: a role for low-molecular-weight effectors in biochemical evolution? In The RNA World (Gesteland, R. F. & Atkins, J. F., eds), pp. 185-204, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
7. Jeoung, Y.-H., Kumar, P. K. R., Young-Ah, S., Taira, K., Nishikawa, S. (1994). Identification of phosphate oxygens that are important for self-cleavage activity of the HDV ribozyme by phosphorothioate substitution interference analysis. Nucl. Acids Res. 22, 3722-3727.
8. Macnaughton, T. B., Wang, Y. J., Lai, M. M. (1993). Replication of hepatitis delta virus RNA: effect of mutations of the autocatalytic sites. J. Virol. 67, 2228-2234.
9. Massire, C., Gaspin, C. & Westhof, E. (1994). DRAWNA: a program for drawing schematic views of nucleic acids. J. Mol. Graph. 12, 201-206.
10. Moazed, D. & Noller, H. F. (1987). Interaction of antibiotics with functional sites in 16 S ribosomal RNA. Nature, 327, 389-394.
11. Olive, J. E., De Abreu, D. M., Rastogi, T., Andersen, A. A., Mittermaier, A. K., Beattie, T. L. & Collins, R. A. (1995). Enhancement of Neurospora VS ribozyme cleavage by tuberactinomycin antibiotics. EMBO J. 14, 3247-3251.
12. Peattie, D. A. (1979). Direct chemical method for sequencing RNA. Proc. Natl Acad. Sci. USA, 76, 1760-1764.
13. Perrotta, A. T. & Been, M. D. (1990). The self-cleaving domain from the genomic RNA of hepatitis delta virus: sequence requirements and the effects of denaturant. Nucl. Acids Res. 18, 6821-6827.
14. Perrotta, A. T. & Been, M. D. (1991). A pseudoknot-like structure required for efficient self-cleavage of hepatitis delta virus RNA. Nature, 350, 434-436.
15. Rogers, J. & Davies, J. (1994). The pseudodisaccharides: a novel class of group I intron splicing inhibitors. Nucl. Acids Res. 24, 4983-4988.
16. Rosenstein, S. P. & Been, M. D. (1990). Self-cleavage of hepatitis delta virus genomic strand RNA is enhanced under partially denaturing conditions. Biochemistry, 29, 8011-8016.
17. Sharmeen, L., Kuo, M. Y., Dineter-Gottlieb, G. & Taylor, J. (1988). Antigenomic RNA of human hepatitis delta virus can undergo self-cleavage. J. Virol. 62, 2674-2679.
18. Stage, T. K., Hertel, K. J. & Uhlenbeck, O. C. (1995). Inhibition of the hammerhead ribozyme by neomycin. RNA, 1, 95-101.
19. Stern, S., Moazed, D. & Noller, H. F. (1988). Structural analysis of RNA using chemical and enzymatic probing monitored by primer extension. Methods Enzymol. 164, 481-489.
20. Streicher, B., von Ahsen, U. & Schroeder, R. (1993). Lead cleavage sites in the core structure of group I intron-RNA. Nucl. Acids Res. 21, 311-317.
21. Suh, Y., Kumar, P. K. R., Taira, K. & Nishikawa, S. (1993). Self-cleavage activity of the genomic HDV ribozyme in the presence of various divalent metal ions. Nucl. Acids Res. 21, 3277-3280.
22. Symons, R. H. (1989). Self-cleavage of RNA in the replication of small pathogens of plants and animals. Trends Biochem. Sci. 14, 445-450.
23. Tanner, N. K., Schaff, S., Thill, G., Petit-Koskas, E., Crain-Denoyelle, A. & Westhof, E. (1994). A three-dimensional model of hepatitis delta virus ribozyme based on biochemical and mutational analyses. Curr. Biol. 4, 488-498.
24. Thill, G., Blumenfeld, M., Lescure, F. & Vasseur, M. (1991). Self-cleavage of a 71 nucleotide-long ribozyme derived from hepatitis delta virus genomic RNA. Nucl. Acids Res. 19, 6519-6525.
25. von Ahsen, U. & Noller, H. F. (1993). Footprinting the sites of interaction of antibiotics with catalytic group I intron RNA. Science, 260, 1500-1502.
26. von Ahsen, U. & Schroeder, R. (1991). Streptomycin inhibits splicing of group I introns by competition with the guanosine substrate. Nucl. Acids Res. 19, 2261-2265.
27. von Ahsen, U., Davies, J. & Schroeder, R. (1991). Antibiotic inhibition of group I ribozyme function. Nature, 353, 368-370.
28. von Ahsen, U., Davies, J. & Schroeder, R. (1992). Non-competitive inhibition of group I intron RNA self-splicing by aminoglycoside antibiotics. J. Mol. Biol. 226, 935-941.
29. Wank, H., Rogers, J., Davies, J. & Schroeder, R. (1994). Peptide antibiotics of the tuberactinomycin family as inhibitors of group I intron RNA splicing. J. Mol. Biol. 236, 1001-1010.
30. Wu, H., Lin, Y., Lin, F., Makino, S., Chang, M. & Lai M. M. C. (1989). Human hepatitis δ virus RNA subfragments contain an autocleavage activity. Proc. Natl Acad. Sci. USA, 86, 1831-1835.
31. Yarus, M. (1988). A specific amino acid binding site composed of RNA. Science, 240, 1751-1758.
32. Zapp, M. L., Stern, S. & Green, M. R. (1993). Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production. Cell, 74, 969-978.